Recent investigations spearheaded by Dr. Martin David Mulligan and his associates at the University of Galway have meticulously tracked nearly 800 individuals participating in the Framingham Heart Study for over sixteen years. Their objective was to ascertain whether vitamin D concentrations, quantified during participants’ thirties, correlated with subsequent alterations observed in the brain during later life stages. The findings revealed that individuals exhibiting elevated circulating vitamin D levels demonstrated a reduced accumulation of tau protein—a protein notorious for forming deleterious tangles in the brains of those afflicted with Alzheimer’s disease—as evidenced by neuroimaging performed approximately 16 years post-measurement. This correlation persisted even after accounting for a broad spectrum of confounding variables, encompassing age, gender, cardiovascular well-being, tobacco consumption, depressive symptoms, and body mass index.
Low vitamin D in midlife may represent a potentially modifiable target to mitigate the risk of neuroimaging signs of preclinical dementia. Image credit: Aloísio Costa Latgé.
Globally, dementia stands as a significant determinant of illness and mortality, impacting an estimated 57 million individuals worldwide.
“Our findings indicate that possessing higher vitamin D levels during middle age might confer a protective effect against the development of tau deposits in the brain, and conversely, that diminished vitamin D levels could potentially serve as a remediable risk factor that, when addressed, may lead to a reduced likelihood of developing dementia,” stated Dr. Mulligan. He further cautioned, “Naturally, these observations necessitate further corroboration through additional empirical studies.”
The research cohort comprises 793 adults, with 53% being female, and an average age of 39 years, all of whom were free from dementia at the time of their initial brain imaging assessment.
Circulating levels of 25-hydroxyvitamin D for these participants were measured between the years 2002 and 2005. Subsequently, between 2016 and 2019, they underwent positron emission tomography (PET) scans designed to detect the presence of both tau and amyloid deposits.
The aggregation of tau protein, particularly within critical brain regions such as the entorhinal cortex and temporal lobes, is widely considered to play a pivotal role in the nascent stages of Alzheimer’s disease.
The investigative team observed that elevated vitamin D concentrations were inversely associated with tau burden, not only throughout the entire brain but also specifically within these particularly susceptible anatomical areas.
“A significant proportion of the study participants, precisely 34%, exhibited suboptimal vitamin D levels, while 5% were actively using vitamin D supplementation,” the researchers noted.
These revelations contribute to an expanding corpus of evidence that delineates a connection between vitamin D status and cerebral well-being. It is noteworthy that the majority of preceding investigations have concentrated on older demographics or on clinical manifestations such as dementia diagnoses, rather than scrutinizing the earliest, preclinical neurological changes.
The scientific cadre posits that vitamin D status during midlife could represent an amenable intervention point for the mitigation of neurodegenerative alterations prior to the onset of overt symptomatology.
Nevertheless, it is imperative to acknowledge that this study does not establish a definitive causal link between vitamin D and the prevention of tau accumulation or dementia. The measurement of vitamin D was conducted at a singular temporal juncture, and the study did not track the ebb and flow of these levels over the intervening years. Furthermore, the efficacy of supplementation in altering brain outcomes was not empirically tested.
“These findings are encouraging, as they point towards a correlation between higher vitamin D levels in early middle age and a diminished tau burden observed, on average, 16 years later,” commented Dr. Mulligan. He emphasized, “Middle age represents a crucial period during which interventions aimed at modifying cardiovascular risk factors can exert a more substantial and enduring impact.”
The findings have been published in the esteemed journal Neurology.
_____
Martin David Mulligan et al. 2026. Association of Circulating Vitamin D in Midlife with Increased Tau-PET Burden in Dementia-Free Adults. Neurology 2 (2): e000057; doi: 10.1212/WN9.0000000000000057
